EMJ GOLD

Here is your April 2026 pharma news roundup. It’s time to reflect on a big month for weight loss drugs and more.

The FDA, on 5 May, authorised the marketing of fruit-flavoured e-cigarettes – the first vapes allowed for sale that are not tobacco or menthol flavoured.

The Games bring together athletes with cognitive disabilities to compete in elite winter sports such as skiing.

The remote prescription of mifepristone is under threat from a lawsuit by Louisiana.

LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.

In good news for UK life sciences investment, two companies have made pledges to build new facilities.

The therapy survodutide works by reducing appetite while also targeting metabolism in the liver.

The EMJ Podcast is a finalist for Audio Content of the Year at the 2026 PPA Awards, shortlisted from more than 260 entries reviewed by a panel of experts.